Dermatology · Lafayette, CO
NPI
1043411473
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
280 Exempla Cir
Lafayette, CO, 80026
Phone (303) 338-4545
Groups this clinician bills Medicare through
Medicare paid, 2022
$1,926
34 services
Medicare patients, 2022
17
Average age 67
Drug cost, 2024
$399K
2,798 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Michael K Lichtman prescribed most often to Medicare patients was Fluorouracil, with 455 prescriptions and refills. In total Michael K Lichtman wrote 2,798 Medicare prescriptions that cost $399K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluorouracil Generic | 455 | 459 | 335 | $17K |
| Clobetasol Propionate Generic | 300 | 324 | 120 | $8,707 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 298 | 330 | 139 | $6,229 |
| Triamcinolone Acetonide Generic | 282 | 293 | 141 | $4,536 |
| Fluocinonide Generic | 147 | 155 | 60 | $2,132 |
| Tacrolimus Generic | 116 | 116 | 62 | $6,087 |
| Ketoconazole Generic | 106 | 108 | 51 | $1,629 |
| Hydrocortisone Generic | 93 | 98 | 54 | $1,143 |
| Metronidazole Generic | 81 | 87 | 44 | $1,259 |
| Gabapentin Generic | 59 | 113 | 18 | $1,180 |
| Doxycycline Hyclate Generic | 55 | 112 | 36 | $1,342 |
| Hydroxychloroquine Sulfate Generic | 51 | 101 | 12 | $1,266 |
| Dutasteride Generic | 47 | 55 | Under 11 | $995 |
| Clindamycin Phosphate Generic | 47 | 49 | 23 | $1,149 |
| Doxycycline Monohydrate Generic | 44 | 85 | 28 | $1,445 |
Brand drugs: 169 claims; generic drugs: 2,629 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Michael K Lichtman were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.